Significance of surgical treatment of liver metastases from gastric cancer

Anticancer Research

Volumn 32, Issue 2, 2012, Pages 665-670

  Miki, Yuichiro ^a   Fujitani, Kazumasa ^a   Hirao, Motohiro ^a   Kurokawa, Yukinori ^a   Mano, Masayuki ^a   Tsujie, Masanori ^a   Miyamoto, Atsushi ^a   Nakamori, Shoji ^a   Tsujinaka, Toshimasa ^a  

^a OSAKA NATIONAL HOSPITAL   (Japan)

Author keywords

Chemotherapy; Gastrectomy; Gastric cancer; Hepatic resection; Liver metastasis; Prognostic factor

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GASTRECTOMY; HUMAN; LIVER METASTASIS; LIVER RESECTION; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STOMACH CANCER; UNIVARIATE ANALYSIS;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LIVER NEOPLASMS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 84856829410     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Okuyama K, Isono K, Juan IK, Onoda S, Ochiai T, Yamamoto Y, Koide Y and Satoh H: Evaluation of treatment for gastric cancer with liver metastasis. Cancer 55: 2498-2505, 1985. (Pubitemid 15115205)
2. Ochiai T, Sasako M, Mizuno S, Kinoshita T, Takayama T, Kosuge T, Yamazaki S and Maruyama K: Hepatic resection for metastatic tumours from gastric cancer: analysis of prognostic factors. Br J Surg 81: 1175-1178, 1994. (Pubitemid 24262949)
3. Miyazaki M, Itoh H, Nakagawa K, Ambiru S, Shimizu H, Togawa A, Shiobara M, Ohtsuka M, Sasada K, Shimizu Y, Yoshioka S, Nakajima N, Suwa T and Kimura F: Hepatic resection of liver metastases from gastric carcinoma. Am J Gastroenterol 92: 490-493, 1997. (Pubitemid 27108188)
4. Elias D, Cavalcanti de Albuquerque A, Eggenspieler P, Plaud B, Ducreux M, Spielmann M, Theodore C, Bonvalot S and Lasser P: Resection of liver metastases from a noncolorectal primary: indications and results based on 147 monocentric patients. J Am Coll Surg 187: 487-493, 1998. (Pubitemid 28506854)
5. Ambiru S, Miyazaki M, Ito H, Nakagawa K, Shimizu H, Yoshidome H, Shimizu Y and Nakajima N: Benefits and limits of hepatic resection for gastric metastases. Am J Surg 235: 86-91, 2001.
6. Imamura H, Matsuyama Y, Shimada R, Kubota M, Nakayama A, Kobayashi A, Kitamura H, Ikegami T, Miyagawa SI and Kawasaki S: A study of factors influencing prognosis after resection of hepatic metastases from colorectal and gastric carcinoma. Am J Gastroenterol 96: 3178-3184, 2001. (Pubitemid 33103756)
7. Saiura A, Umekita N, Inoue S, Maeshiro T, Miyamoto S, Matsui Y, Asakage M and Kitamura M: Clinicopathological features and outcome of hepatic resection for liver metastasis from gastric cancer. Hepatogastroenterology 49: 1062-1065, 2002. (Pubitemid 34809787)
8. Okano K, Maeba T, Ishimura K, Karasawa Y, Goda F, Wakabayashi H, Usuki H and Maeta H: Hepatic resection for metastatic tumors from gastric cancer. Ann Surg 235: 86-91, 2002. (Pubitemid 34062403)
9. Zacherl J, Zacherl M, Scheuba C, Steininger R, Wenzl E, Mühlbacher F, Jakesz R and Längle F: Analysis of hepatic resection of metastasis originating from gastric adenocarcinoma. J Gastrointest Surg 6: 682-689, 2002. (Pubitemid 40433486)
10. Sakamoto Y, Ohyama S, Yamamoto J, Yamada K, Seki M, Ohta K, Kokudo N, Yamaguchi T, Muto T and Makuuchi M: Surgical esection of liver metastases of gastric cancer: an analysis of a 17-year experience with 22 patients. Surgery 133: 507-511, 2003. (Pubitemid 36638222)
11. Shirabe K, Shimada M, Matsumata T, Higashi H, Yakeishi Y, Wakiyama S, Ikeda Y, Ezaki T, Fukuzawa S, Takenaka K, Kishikawa K, Ikeda T, Taguchi K, Maehara Y and Sugimachi K: Analysis of the prognostic factors for liver metastasis of gastric cancer after hepatic resection: a multi-institutional study of the indications for resection. Hepatogastroenterology 50: 1560-1563, 2003. (Pubitemid 37186532)
12. Roh HR, Suh KS, Lee HJ, Yang HK, Choe KJ and Lee KU: Outcome of hepatic resection for metastatic gastric cancer. Am Surg 71: 95-99, 2005. (Pubitemid 41725304)
13. Sakamoto Y, Sano T, Shimada K, Esaki M, Saka M, Fukagawa T, Katai H, Kosuge T and Sasako M: Favorable indications for hepatectomy in patients with liver metastasis from gastric cancer. J Surg Oncol 95: 534-539, 2007. (Pubitemid 47177216)
14. Koga R, Yamamoto J, Ohyama S, Saiura A, Seki M, Seto Y and Yamaguchi T: Liver resection for metastatic gastric cancer: experience with 42 patients including eight long-term survivors. Jpn J Clin Oncol 37: 836-842, 2007. (Pubitemid 350259002)
15. Cheon SH, Rha SY, Jeung HC, Im CK, Kim SH, Kim HR, Ahn JB, Roh JK, Noh SH and Chung HC: Survival benefit of combined curative resection of the stomach (D2 resection) and liver in gastric cancer patients with liver metastases. Ann Oncol 19: 1146-1153, 2008. (Pubitemid 351796341)
16. Makino H, Kunisaki C, Izumisawa Y, Tokuhisa M, Oshima T, Nagano Y, Fujii S, Kimura J, Takagawa R, Kosaka T, Ono HA, Akiyama H, Tanaka K and Endo I: Indication for hepatic resection in the treatment of liver metastasis from gastric cancer. Anticancer Res 30: 2367-2376, 2010.
17. Boku N, Yamamoto S, Fukuda H, Shirao K, Doi T, Sawaki A, Koizumi W, Saito H, Yamaguchi K, Takiuchi H, Nasu J and Ohtsu A: Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study. Lancet Oncol 10: 1063-1069, 2009.
18. Miyagaki H, Fujitani K, Tsujinaka T, Hirao M, Yasui M, Kashiwazaki M, Ikenaga M, Miyazaki M, Mishima H and Nakamori S: The significance of gastrectomy in advanced gastric cancer patients with non-curative factors. Anticancer Res 28: 2379-2384, 2008.
19. Fujitani K, Yang HK, Kurokawa Y, Park do J, Tsujinaka T, Park BJ, Fukuda H, Noh SH, Boku N, Bang YJ, Sasako M and Lee JI: Randomized controlled trial comparing gastrectomy plus chemotherapy with chemotherapy alone in advanced gastric cancer with a single non-curable factor: Japan Clinical Oncology Group Study JCOG 0705 and Korea Gastric Cancer Association Study KGCA01. Jpn J Clin Oncol 38: 504-506, 2008.
20. Japanese Gastric Cancer Association: Japanese Classification of Gastric Carcinoma, 2nd English Edition. Gastric Cancer 1: 10-24, 1998.
21. Koizumi W, Narahara H, Hara T, Takagane A, Akiya T, Takagi M, Miyashita K, Nishizaki T, Kobayashi O, Takiyama W, Toh Y, Nagaie T, Takagi S, Yamamura Y, Yanaoka K, Orita H and Takeuchi M: S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol 9: 215-221, 2008.
22. Hartgrink HH, Putter H, Klein Kranenbarg E, Bonenkamp JJ, and van de Velde CJ: Dutch Gastric Cancer Group: Value of palliative resection in gastric cancer. Br J Surg 89: 1438-1443, 2002.